"Pneumonia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infection of the lung often accompanied by inflammation.
Descriptor ID |
D011014
|
MeSH Number(s) |
C08.381.677 C08.730.610
|
Concept/Terms |
Lobar Pneumonia- Lobar Pneumonia
- Lobar Pneumonias
- Pneumonias, Lobar
- Pneumonia, Lobar
Experimental Lung Inflammation- Experimental Lung Inflammation
- Experimental Lung Inflammations
- Inflammation, Experimental Lung
- Lung Inflammation, Experimental
- Lung Inflammations, Experimental
Pneumonitis- Pneumonitis
- Pneumonitides
- Pulmonary Inflammation
- Inflammation, Pulmonary
- Inflammations, Pulmonary
- Pulmonary Inflammations
- Lung Inflammation
- Inflammation, Lung
- Inflammations, Lung
- Lung Inflammations
|
Below are MeSH descriptors whose meaning is more general than "Pneumonia".
Below are MeSH descriptors whose meaning is more specific than "Pneumonia".
This graph shows the total number of publications written about "Pneumonia" by people in this website by year, and whether "Pneumonia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1996 | 1 | 0 | 1 |
1998 | 0 | 1 | 1 |
2000 | 0 | 2 | 2 |
2001 | 1 | 0 | 1 |
2002 | 1 | 3 | 4 |
2003 | 1 | 0 | 1 |
2004 | 1 | 3 | 4 |
2005 | 2 | 2 | 4 |
2006 | 3 | 0 | 3 |
2007 | 1 | 2 | 3 |
2008 | 1 | 1 | 2 |
2009 | 1 | 2 | 3 |
2010 | 2 | 1 | 3 |
2011 | 8 | 5 | 13 |
2012 | 4 | 3 | 7 |
2013 | 5 | 2 | 7 |
2014 | 2 | 1 | 3 |
2015 | 4 | 1 | 5 |
2016 | 3 | 3 | 6 |
2017 | 1 | 1 | 2 |
2018 | 3 | 5 | 8 |
2019 | 1 | 2 | 3 |
2020 | 3 | 7 | 10 |
2021 | 2 | 1 | 3 |
2022 | 7 | 0 | 7 |
2023 | 4 | 0 | 4 |
2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pneumonia" by people in Profiles.
-
Preferences for Management of Pediatric Pneumonia: A Clinician Survey of Artificially Generated Patient Cases. Pediatr Emerg Care. 2025 Jan 01; 41(1):41-49.
-
Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD+/SIRT1/AMPK pathway-mediated effects on mitochondrial function and cellular metabolism. Eur J Med Res. 2024 Jan 20; 29(1):68.
-
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study. Lancet Haematol. 2024 Jan; 11(1):e15-e26.
-
Sphingosine-1-Phosphate Receptor 3 Induces Endothelial Barrier Loss via ADAM10-Mediated Vascular Endothelial-Cadherin Cleavage. Int J Mol Sci. 2023 Nov 08; 24(22).
-
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2023 09; 24(9):989-1001.
-
Accuracy of infection reporting in US nursing home ratings. Health Serv Res. 2023 10; 58(5):1109-1118.
-
Biotin-dependent cell envelope remodelling is required for Mycobacterium abscessus survival in lung infection. Nat Microbiol. 2023 03; 8(3):481-497.
-
Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure. Nat Commun. 2022 11 03; 13(1):6615.
-
Editorial Comment: Radiomics and Pneumonia-Type Invasive Mucinous Carcinoma-A Future Promise. AJR Am J Roentgenol. 2023 Feb; 220(2):235.
-
Immunoglobulin-G4 related disease: an unusual cause of paediatric pneumonia. Br J Hosp Med (Lond). 2022 08 02; 83(8):1.